Precision-oncology diagnostics company applying gene-expression biology to liquid-biopsy sequencing through its ExpressCT fragmentomics platform and biomarker services.
At a glance
- Founded: 2011
- HQ: Durham
- Sector: Biotech
- Stage: Series C
- Total raised: $2.0M
Listed roles
All Triangle rolesChecking listed roles…
The rest of this record is behind a free account.
Founders, funding history, investor connections, and recent signals load on this page as soon as you sign in. Accounts open immediately.